A commonly prescribed anxiety medication, Clonazepam, is undergoing an expanded recall due to concerns that some cartons may contain the incorrect drug strength, which could pose serious health risks.
The manufacturer, Endo, has provided the lot codes of the recalled products on the U.S. FDA website. Fortunately, there have been no reported cases of adverse effects related to the recalled items.
Comments